tiprankstipranks
LENZ Therapeutics Secures $30 Million Through Private Share Sale
Company Announcements

LENZ Therapeutics Secures $30 Million Through Private Share Sale

Don't Miss our Black Friday Offers:

LENZ Therapeutics (LENZ) has issued an announcement.

LENZ Therapeutics, Inc. has struck a deal with Ridgeback Capital Investment, L.P. for a private sale of over 1.5 million shares at $19 each, aiming to raise around $30 million. The shares, which are not yet registered under U.S. securities laws, are expected to be sold by July 17, 2024, with conditions. Additionally, LENZ Therapeutics plans to file for a resale registration of these shares with the SEC within 60 days post-closing, ensuring compliance and resale ability for the investor. The announcement was made public via a press release on July 15, 2024.

For a thorough assessment of LENZ stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPatent Challenges Threaten Lenz Therapeutics’ Market Strategy and Financial Stability
TheFlyLenz Therapeutics price target raised to $36 from $32 at Leerink
TheFlyLenz Therapeutics reports Q3 EPS (38c), consensus (46c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App